Back to Results
First PageMeta Content
Private equity / Venture capital / Independent Investigations Group / Financial economics / Finance / Investment


Medisse, A Dutch biomaterial company, raises €2,6 Million funding for its lead product FlexiSurge Adhesion Barrier Ede, 28 January 2013, Medisse B.V., announced the closure of a Series B equity financing round for the
Add to Reading List

Document Date: 2013-02-01 07:15:08


Open Document

File Size: 79,33 KB

Share Result on Facebook

City

Ede / /

Company

ABN- AMRO / LBO & Expansion Capital / Renewable Energy / PPM Oost / Omnes Capital / BioGeneration Ventures / Medisse B.V. / Omnes Capital (formerly Crédit Agricole Private Equity) Omnes Capital / BioGeneration Ventures BioGeneration Ventures / Forbion Capital Partners / /

Continent

Europe / /

Country

Germany / Belgium / Netherlands / /

Currency

EUR / /

/

Event

Business Partnership / Funding / FDA Phase / /

Facility

University of Leiden / /

IndustryTerm

venture capital / soft tissue applications / resorbable products / technology validation / /

Organization

United Nations / University of Leiden / Dutch Ministry of Economic Affairs / /

Person

Joost Holthuis / Sandra de Vos / Marius Prins / /

/

Position

manager of IIG / CEO / Chairman / managing director / fund manager / /

Product

FlexiSurge Adhesion Barrier / FlexiSurge® Adhesion Barrier / /

ProvinceOrState

Gelderland / /

Technology

Genomics / /

URL

www.ppmoost.nl / www.medisse.com / www.omnescapital.com / www.biogenerationventures.com / /

SocialTag